Medical Affairs Director, Rare Epilepsies (DEE) – US Launch

Lundbeck LLC; Boston (MA); Vor Ort; USD 260.000 - 290.000; Vollzeit

Zusammenfassung

Lundbeck LLC, a global biopharmaceutical company focused on brain health, seeks a Medical Affairs Director for Rare Epilepsies to lead US medical strategy related to DEE and bexicaserin. This role drives launch readiness, evidence generation, external engagement, and scientific communication across cross-functional teams.

You will partner with HEOR, Commercial, Regulatory, Clinical Development, Compliance and others to ensure scientifically rigorous, compliant programs and impactful medical

Qualifikationen

• Accredited advanced scientific or clinical degree (MD, PharmD, PhD or MS).
• 5+ years of progressive, non-field-based Medical Affairs experience in pharma/biotech.
• Minimum 2+ years contributing to medical strategy, launch readiness, evidence generation.

Aufgaben

• Provide medical leadership across DEE and bexicaserin US launch readiness.
• Lead cross-functional medical strategy, education, publication and congress planning.
• Engage with investigators, KOLs, advocacy groups and healthcare professionals.
• Synthesize external insights to inform US and global medical strategies.
• Co-create with Global Medical Affairs to ensure US insights inform messaging and data stories.
• Serve as medical reviewer in promotional review processes.

Kenntnisse

Medical Affairs

Launch readiness

External engagement

Scientific communications

Regulatory knowledge

Evidence generation

Ausbildung

MD/PhD/PharmD/MS

Jobbeschreibung

Lundbeck LLC, a global biopharmaceutical company focused on brain health, seeks a Medical Affairs Director for Rare Epilepsies to lead US medical strategy related to DEE and bexicaserin. This role drives launch readiness, evidence generation, external engagement, and scientific communication across cross-functional teams.

You will partner with HEOR, Commercial, Regulatory, Clinical Development, Compliance and others to ensure scientifically rigorous, compliant programs and impactful medical